Sybil Hosek
Overview
Explore the profile of Sybil Hosek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
2416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Roberts S, Mancuso N, Williams K, Nabunya H, Mposula H, Mugocha C, et al.
J Int AIDS Soc
. 2023 Nov;
26(11):e26189.
PMID: 37936551
Introduction: Effective use of pre-exposure prophylaxis (PrEP) has been low among adolescent girls and young women (AGYW) in sub-Saharan Africa. The MTN-034/REACH trial offered AGYW a menu of adherence support...
12.
Fynn L, Gill K, Wallace M, Atujuna M, Duyver M, Ngcobo P, et al.
BMC Public Health
. 2023 Nov;
23(1):2143.
PMID: 37919697
Background: Advances in biomedical HIV prevention will soon offer young women a choice of HIV prevention methods, including various pre-exposure prophylaxis (PrEP) modalities such as daily oral pills, dapivirine vaginal...
13.
Nair G, Celum C, Szydlo D, Brown E, Akello C, Nakalega R, et al.
Lancet HIV
. 2023 Oct;
10(12):e779-e789.
PMID: 37898146
Background: Half of new HIV acquisitions in Africa occur in adolescent girls and young women. Pre-exposure prophylaxis (PrEP) with oral tenofovir disoproxil fumarate plus emtricitabine or the monthly dapivirine vaginal...
14.
Beauchamp G, Hosek S, Donnell D, Chan K, Anderson P, Dye B, et al.
AIDS Behav
. 2023 Sep;
28(5):1512-1521.
PMID: 37768427
To develop effective PrEP adherence interventions, it is important to understand the interplay between disclosure of pre-exposure prophalxis (PrEP) use, social support, and PrEP adherence. We leveraged the HPTN 082...
15.
de Vos L, Mudzingwa E, Fynn L, Atujuna M, Mugore M, Gandhi M, et al.
J Int AIDS Soc
. 2023 Sep;
26(9):e26175.
PMID: 37758649
Introduction: Adolescent girls and young women (AGYW) face barriers that jeopardize their prevention-effective use of daily oral pre-exposure prophylaxis (PrEP). We sought to understand factors that influence AGYW's prolonged breaks...
16.
Hosek S, Stranix-Chibanda L
J Int AIDS Soc
. 2023 Jul;
26 Suppl 2:e26098.
PMID: 37439060
No abstract available.
17.
Ngure K, Friedland B, Szydlo D, Roberts S, Garcia M, Levy L, et al.
PLoS One
. 2023 Jun;
18(6):e0287525.
PMID: 37352296
Introduction: Adolescent girls and young women (AGYW) in sub-Saharan Africa are disproportionately affected by the HIV epidemic and face an array of challenges using proven behavioral and biomedical prevention methods....
18.
Beauchamp G, Donnell D, Hosek S, Anderson P, Chan K, Dye B, et al.
BMC Womens Health
. 2023 May;
23(1):276.
PMID: 37208687
Background: Trust is an important cornerstone of patient-provider communication. Accurate reporting of pre-exposure prophylaxis (PrEP) adherence is vital for providers to determine who needs adherence support, especially adolescent girls and...
19.
Daniels J, de Vos L, Bezuidenhout D, Atujuna M, Celum C, Hosek S, et al.
PLOS Glob Public Health
. 2023 Mar;
3(1):e0000636.
PMID: 36962727
There is limited understanding of the dynamic interplay between adolescent girl's and young women's (AGYW) disclosure and social support for using oral pre-exposure prophylaxis (PrEP) and adherence. Towards this, we...
20.
Beauchamp G, Hosek S, Donnell D, Chan K, Flaherty B, Anderson P, et al.
PLoS One
. 2023 Feb;
18(2):e0281728.
PMID: 36827440
Background: African adolescent girls and young women (AGYW) represent a large proportion of new HIV infections, a priority population for pre-exposure prophylaxis (PrEP), but adherence remains a challenge. A reliable,...